key: cord-0844947-r67jidlr authors: Di Lecce, Valentina; Carpagnano, Giovanna Elisiana; Pierucci, Paola; Quaranta, Vitaliano Nicola; Barratta, Federica; Zito, Annapaola; Buonamico, Enrico; Resta, Onofrio title: Baseline characteristics and outcomes of COVID-19 patients admitted to a Respiratory Intensive Care Unit (RICU) in Southern Italy date: 2020-11-06 journal: Multidiscip Respir Med DOI: 10.4081/mrm.2020.704 sha: 13c2af0339e616cf2c8af5071e34a3162037fb4f doc_id: 844947 cord_uid: r67jidlr The recent Coronavirus disease 19 (COVID-19) pandemic, first in China and then also in Italy, brought to the attention the problem of the saturation of Intensive Care Units (ICUs). Almost all previous reports showed that in ICU less than half of patients were treated with invasive mechanical ventilation (IMV) and the rest of them with non-invasive respiratory support. This highlighted the role of respiratory intensive care units (RICUs), where patients with moderate to severe respiratory failure can be treated with non-invasive respiratory support, avoiding ICU admission. In this report, we describe baseline characteristics and clinical outcomes of 97 patients with moderate to severe respiratory failure due to COVID-19 admitted to the RICU of the Policlinico of Bari from March 11(th) to May 31(st) 2020. In our population, most of the subjects were male (72%), non-smokers (76%), with a mean age of 69.65±14 years. Ninety-one percent of patients presented at least one comorbidity and 60% had more than two comorbidities. At admission, 40% of patients showed PaO(2)/FiO(2) ratio between 100 and 200 and 17% showed Pa0(2)/FiO(2) ratio <100. Mean Pa0(2)/FiO(2) ratio at admission was 186.4±80. These patients were treated with non-invasive respiratory support 40% with CPAP, 38% with BPAP, 3% with HFNC, 11% with standard oxygen therapy or with IMV through tracheostomy (patients in step down from ICU, 8%). Patients discharged to general ward (GW) were 51%, 30% were transferred to ICU and 19% died. To the best of our knowledge, this is one of the few described experiences of patients with respiratory failure due to COVID-19 treated outside the ICU, in a RICU. Outcomes of our patients, characterized by several risk factors for disease progression, were satisfactory compared with other experiences regarding patients treated with non-invasive respiratory support in ICU. The strategical allocation of our RICU, between ED and ICU, might have positively influenced clinical outcomes of our patients. Since December 2019, the world is in the grip of the Coronavirus Disease 19 . The clinical spectrum of this infection, caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), appears to be wide, encompassing asymptomatic infection, mild upper respiratory tract illness and severe viral pneumonia with acute respiratory failure (ARF), needing admission to intensive care units (ICU) in a high proportion of cases [1] . This brought to the worldwide attention the problem of ICU saturation, which negatively affected patient survival. Data from China, where SARS-CoV-2 spread firstly, show that the percentage of patients who required admission to ICU varied from 5% to 32% [2] . Furthermore, as reported in a recent study by Grasselli et al., in Chinese ICUs invasive mechanical ventilation (IMV) was performed only in less than half of patients, and noninvasive ventilation (NIV) and high flow nasal cannula (HFNC) were used much more frequently than in other hospital wards [3, 4] . This highlighted the role of respiratory intensive care units (RICUs), where patients with moderate to severe respiratory failure can be treated with non-invasive respiratory support, avoiding ICU admission. However, COVID-19 patients with ARF may rapidly develop severe respiratory distress, needing suddenly intubation and transfer to ICU. Thus, another important aspect to consider in the COVID-19 hospitals emergency plans is the location of the RICU. In this report, we described baseline characteristics and outcomes of patients with moderate to severe ARF due to COVID-19 admitted to the RICU of a large university hospital in Southern Italy. This is a retrospective, observational single centre study. We obtained medical records and compiled data from hospitalized adult inpatients, affected by moderate to severe ARF due to COVID-19 related pneumonia, that were in our RICU of Teaching Hospital "Policlinico" of Bari from March 11 th to May 31 st 2020. To stage the severity of acute respiratory failure we used the classification provided in the Berlin definition for Acute Respiratory Distress Syndrome (ARDS): mild, with 200 mm Hg